Pediatric Multiple Sclerosis in the United Arab Emirates: Characteristics From a Multi-Center Study and Global Comparison (P4.348) (original) (raw)
Related papers
Journal of child neurology, 2018
We delineate the clinical characteristics, incidence, and prevalence of pediatric-onset multiple sclerosis in Abu Dhabi, United Arab Emirates, from 2010 to 2014. Eighty-two patients (65% female) were identified. Fifty-three (64.6%) were Emiratis (45 from Abu Dhabi and 8 from 5 other emirates) and 29 were expatriates. Mean age of onset was 15.9 years overall, 15.3 years in males and 16.3 years in females. Patients with onset before age 12 years presented with visual symptoms while those with onset after age 12 years presented with a mixture of visual, motor and sensory symptoms. Interferon beta-1a was the most frequently used disease-modifying therapy (48%). In Abu Dhabi Emirati nationals, the age- and sex-adjusted prevalences were 26/100 000 for males and 36/100 000 for females. The total incidence in Emirati nationals from 2010 to 2014 was 2.3/100 000 for ages 10 to 14 years and 7.2/100 000 for ages 15 to 19 years. By comparison with international cohorts, the incidence of pediatri...
Prevalence of Pediatric Onset Multiple Sclerosis in Saudi Arabia
Multiple Sclerosis International
Background. The prevalence of multiple sclerosis (MS) appears to be increasing worldwide. However, data on the pediatric onset of MS is lacking, particularly in developing countries. Objective. This study is aimed at reporting the current burden of the pediatric onset of MS in the five regions of Saudi Arabia. Methods. This study used relevant data from the National Saudi MS Registry that was operational between 2015 and 2018. The data on patients with pediatric onset MS from all the hospitals included in the registry was retrospectively analyzed using the age of diagnosis. Patients who were 1-18 years old when diagnosed were included in the analysis. Results. The registry included 287 patients with pediatric onset MS, with a mean age of diagnosis at 15.7 (SD: 2.06). 74.2% of the participants were females. For the included hospitals, the estimated prevalence of pediatric MS was at 2.73/100,000 pediatric Saudi population. The prevalence of pediatric MS in the remaining nonparticipant...
Incidence and prevalence of pediatric onset multiple sclerosis in Kuwait: 1994-2013
Journal of the neurological sciences, 2015
This study aimed to assess the incidence and prevalence of pediatric-onset multiple sclerosis (POMS) along with temporal and gender differentials in these estimates in Kuwait. We identified MS patients with pediatric (age <18 years) onset between 1994 and 2013 from national MS registry. Year and gender-specific incidence rate and prevalence estimates were computed. Multivariable Poisson regression analyses of time-series cross-sectional panel data were conducted to evaluate temporal and gender related variations in yearly POMS incidence rate and prevalence. 122 POMS patients were identified; of which 90 (73.8%) were females. During 2013, POMS incidence rate and prevalence (per 100,000) were 2.1 and 6.0 respectively. Multivariable Poisson regression model revealed statistically significant 5% increase in POMS incidence rate (p=0.002) and 6% increase in prevalence (p<0.001) from 1994 to 2013. Furthermore, during the study period, female children were more likely to have higher P...
Pediatric Multiple Sclerosis in Tunisia: A Retrospective Study over 11 Years
BioMed Research International
Introduction. Pediatric multiple sclerosis (pMS) is a rare demyelinating disorder with an onset before the age of 18 years. In this study, we aimed to investigate the characteristics of pMS in Tunisian children. Patients and Methods. We conducted a retrospective study over 11 years (2005–2016) including all patients diagnosed with pMS according to the International Pediatric Multiple Sclerosis Study Group (IPMSSG) criteria of 2012 and followed up in a tertiary care research center. Epidemiological, clinical, neuroimaging, laboratory, and therapeutic data were collected and analyzed. Results. There were 21 patients. The male-female ratio was 1 : 3. Mean age at onset was 11 years (range: 3–17 years). Three patients had type 1 diabetes. Polyfocal presentation was preponderant (81%) with motor dysfunction in 57% of patients. Paroxysmal dystonia was noticed in 24%. All patients were diagnosed with relapsing-remitting form. Interferon beta was prescribed in 80% with a reduction of annual ...
International Journal of Neuroscience, 2014
We have reviewed the clinical literature with reference to the local applicability of guidelines for the diagnosis and management of multiple sclerosis (MS) in the Middle East. There is a substantial burden of MS in the region: the prevalence of the disease appears to have increased markedly in recent decades, with a faster rate of increase in female vs. male patients. The aetiology and presentation of MS appears to be broadly similar in the Middle East to that in other regions. Interferon-β is the most commonly used treatment for MS in the Middle East, as elsewhere, although it is unclear to what extent economic constraints act as a barrier to accessing this treatment. Similarly, limited available data suggest that the availability of MRI scanners appears to be lower in the Middle East than in more developed nations. Little is known concerning other potential barriers to treatment. There is a need for further research on aspects of management of MS beyond the pharmacological aspects of treatment to assess fully the potential barriers to the adoption of international guidelines for the diagnosis and management of the disease in the Middle East.
Prevalence of Multiple Sclerosis in Dubai, United Arab Emirates
International Journal of Neuroscience, 2011
Background: The prevalence of multiple sclerosis (MS) is rapidly changing. Objectives: To determine the prevalence and incidence of MS in Dubai, UAE. Methods: Data for all MS patients fulfilling McDonald criteria and registered in the Neurology Department, Rashid Hospital, Dubai between January 01, 2000 to December 12, 2007 were analyzed. Results: Two hundred and eighty-four MS patients were identified of which 158 (55.6%) were Dubai Natives and 126 (44.4%) Immigrants. In the Dubai Native population, the female to male ratio was 2.85:1. Motor manifestation was the commonest presentation 72.78% followed by sensory symptom 48.41%. The median and mean expanded disability status scale (EDSS) was 1.5 and 2.38 respectively. The mean age of onset was 26.
Pediatric-onset multiple sclerosis in Egypt: a multi-center registry of 186 patients
Neuropsychiatric disease and treatment, 2018
Although the frequency of pediatric-onset multiple sclerosis (POMS) has increased in recent decades, it is still highly uncommon, which creates a need for the involvement of more registries from various clinical centers. To characterize the demographic, clinical, and paraclinical features of Egyptian patients with POMS. A retrospective chart review study was undertaken on 237 Egyptian patients with demyelinating events which started before the age of 18 years who attended one of five tertiary referral centers in Cairo, Egypt. Multiple sclerosis was diagnosed in 186 patients, 47 (25.27%) patients had disease onset before the age of 12 years; "early-onset pediatric multiple sclerosis (EOPMS)". The mean age of disease onset was (14.13±2.49 years), with a female:male ratio of 1.62:1, none of the enrolled patients had a primary progressive course (PPMS), whereas 10 patients (5.38%) had a secondary progressive form. Approximately two-thirds of the patients had monofocal disease ...
Neurosciences, 2018
To study the basic demographic and disease characteristics of multiple sclerosis)MS(in the Southwest Region of the Kingdom of Saudi arabia. Methods: This is a retrospective study on demographics and risk factors of 82 MS cases registered in the Armed Forces Hospital, Khamis Mushayt, and the Aseer Central Hospital, Abha, Kingdom of Saudi Arabia. The study was conducted from April 2017 to April 2018. Data was gathered through interview questionnaires and review of medical records. Frequencies, percentages, means, and standard deviations)SD(were used for descriptive statistics. Chi-square and Fisher exact tests were used to investigate differences between male and female patients at 95% confidence intervals)CI(. Differences were considered statistically significant at p<0.05. Results: Out of the total of 82 patients, 50 were female, yielding a female-to-male ratio of 1.56:1. The mean age at disease diagnosis was 30.50±9.29 years. As compared to females, the proportion of male patients in the younger age group at disease diagnosis was significantly higher)78.1%, p=0.003(than that in the older age group. Mean disease duration was 4.07±3.65 years. The most common variant of the disease was the remitting-relapsing type)64.6%(. Optic symptoms)37.8%(were the most common predominant symptom at diagnosis. Conclusion: This study provides the baseline information about patients with MS in the Aseer region in the Kingdom of Saudi Arabia, and offers useful insights into male-female differences in the manifestation of this disease. Further prospective studies are needed.
Multiple sclerosis in the Arabian Gulf countries: A consensus statement
Journal of Neurology, 2013
The epidemiology of multiple sclerosis (MS) is rapidly changing in many parts of the world. Based on the Kurtzke classification, the Arabian Gulf Region is located in a low-risk zone for MS; however, recent studies suggest a moderate-to-high prevalence nearby (31-55 MS per 10,0000 individuals), with an increase in incidence in recent years. The relapsing-remitting disease course ratio is 2.5:1 versus the primary progressive type. In a geographic area that was previously associated with low prevalence; the recent high prevalence and fast rising incidence of MS in the gulf countries, encouraged the neurologists of this region to meet in a consensus panel, in order to share our latest findings in terms of MS epidemiology and consent on MS management in the Arabian Gulf. Therefore 20 key opinion leader neurologists and MS experts representing various countries of the Arabian Gulf have met in Dubai on the 2 and 3 February 2012, they shared their latest epidemiological findings, discussed recent MS aspects in the region, and consented on MS management relevantly to this geographic area.